Norfolk Defective Drug Lawyer
Pharmaceutical companies spend billions convincing patients and physicians that their drugs are safe and effective. When that promise turns out to be false, the consequences can be devastating. A medication prescribed to treat one condition can cause organ damage, stroke, cancer, or death. The drug still sits on pharmacy shelves. The company still collects revenue. And the patient is left managing a harm nobody warned them about. A Norfolk defective drug lawyer at Montagna Law works to hold pharmaceutical manufacturers, distributors, and prescribers accountable when a dangerous drug causes serious injury to someone in the Hampton Roads area.
Why Pharmaceutical Drug Cases Are Different From Other Injury Claims
Most personal injury cases involve a clear event, a crash, a fall, a workplace accident. Defective drug cases are different. The harm often develops quietly over time. A patient takes a medication for months or years before a serious side effect appears. By then, the causal connection between the drug and the injury may not be obvious, and pharmaceutical companies invest heavily in making sure it stays that way.
Drug manufacturers operate with access to clinical trial data, post-market surveillance reports, and internal safety analyses that never reach the public or prescribing physicians. When that data reveals risks that were downplayed, withheld, or buried, injured patients have legal recourse. Virginia product liability law allows injured individuals to bring claims based on manufacturing defects, design defects, and failures to adequately warn about known risks. Each theory requires different evidence and a different approach to building the case.
- A manufacturing defect claim applies when a specific batch or lot of a drug was contaminated or improperly produced, even if the underlying formula was approved.
- A design defect claim applies when the drug’s formulation itself creates an unreasonable risk of harm regardless of how it was manufactured.
- A failure to warn claim applies when a drug company knew or should have known about a serious risk and did not adequately disclose it to patients or prescribers.
- Federal preemption doctrines can limit certain state law claims against brand-name manufacturers, but not all claims, and generic drug liability rules differ in important ways.
- Virginia’s two-year statute of limitations for personal injury claims applies, but the discovery rule may extend that deadline when an injury was not immediately recognizable as drug-related.
Many defective drug cases involve prescription medications that received FDA approval. That approval does not immunize a drug company from liability. The FDA process is based on the information the manufacturer submits, and companies have faced significant judgments and settlements after it emerged that they withheld or misrepresented safety data during the approval process.
What the Science Actually Shows: Linking a Drug to a Specific Injury
One of the hardest parts of a pharmaceutical injury case is proving causation. Even when a drug has a known risk profile, a defendant company will argue that your injury resulted from an underlying condition, a different medication, lifestyle factors, or natural disease progression. Defeating that argument requires more than a treating physician’s opinion. It requires a thorough review of the medical literature, the drug’s regulatory history, and the specific facts of your case.
Cases involving drugs with acknowledged black box warnings, drugs that were later recalled, or drugs tied to multidistrict litigation often have a stronger causation foundation to work from. But even in those situations, the case must be tailored to the individual plaintiff. Courts and juries want to understand not just that a drug can cause harm generally, but that it caused this injury in this patient given the relevant medical history and circumstances.
At Montagna Law, we approach pharmaceutical cases with the same detailed investigation we apply to complex truck accident and maritime injury claims. Building the case requires early action, thorough preservation of medical records and prescription histories, and a clear picture of how the drug’s known risks compared to what patients and physicians were actually told.
Drug Companies, Distributors, and the Supply Chain: Who Can Be Held Responsible
Pharmaceutical liability does not always end with the manufacturer. Depending on the facts of a case, additional parties may share responsibility for an injury caused by a defective or dangerous drug.
Wholesale distributors can face liability when they handled a product they knew or should have known was compromised. Pharmacies may be liable in cases where a drug was dispensed incorrectly, mislabeled, or substituted with a different formulation without adequate notification. In some cases, a prescribing physician or hospital may bear responsibility for failing to recognize or disclose contraindications, known drug interactions, or patient-specific risk factors that should have changed the prescribing decision.
Identifying all potentially liable parties matters for practical reasons. A pharmaceutical manufacturer may have significant resources to contest a claim over years of litigation. Other parties in the supply chain may have insurance coverage that becomes relevant to recovery. And in cases where a manufacturer has filed for bankruptcy following widespread litigation, understanding the full landscape of potentially responsible parties becomes critical to securing any meaningful compensation.
Our firm has experience handling claims against corporate defendants and their insurers. We take the same approach in defective drug cases as we do when going up against trucking companies and their defense teams: prepare thoroughly, move quickly to preserve evidence, and do not let an insurance company’s early positioning dictate the value of a legitimate claim.
Compensation for Pharmaceutical Injuries in Virginia
The harms caused by a defective drug can be extensive and long-lasting. Patients who develop serious conditions as a result of a dangerous medication often face significant medical expenses, repeated treatments, and in some cases, permanent disability. Virginia law allows injured patients to seek compensation for the full scope of those losses.
Recoverable damages typically include past and future medical expenses related to the drug-induced injury, lost income and reduced earning capacity, physical pain and suffering, emotional and psychological harm, and in cases involving particularly egregious corporate conduct, punitive damages. Punitive damages in Virginia require proof that a defendant acted with actual malice or willful and wanton conduct, a standard that some pharmaceutical cases can meet when internal documents show a company deliberately concealed known dangers.
For families who lost someone due to a dangerous drug, Virginia’s wrongful death statute allows surviving family members to pursue compensation through the estate. The same underlying theories of liability apply, and the damages available reflect both the economic and non-economic losses the family has suffered.
Because pharmaceutical injuries often develop over time and carry ongoing medical consequences, calculating the full measure of damages requires careful attention. Settling too early, before the full extent of an injury is known, can leave a victim without the resources needed for continued treatment and recovery. We work to understand the complete picture of what a client has lost before agreeing to any resolution.
Questions About Dangerous Drug Claims in Virginia
Can I file a claim if the drug I was taking received FDA approval?
Yes. FDA approval does not bar a state law product liability claim. Approval is granted based on the information submitted to the agency, and companies have faced liability when it was established that they withheld or misrepresented safety data. In some circumstances involving brand-name drug labeling, federal preemption can limit certain claims, but this is a fact-specific analysis, not a blanket bar.
What if my doctor knew about the risks and still prescribed the drug?
This can affect the case but does not necessarily end it. The question is whether the prescribing physician had access to complete and accurate information from the manufacturer. If a company’s warnings were inadequate, the physician’s awareness of partial risk information may not insulate the manufacturer from liability. In some situations, the prescriber may also share responsibility.
What if the drug has already been recalled?
A recall actually supports a defective drug claim because it confirms the manufacturer or FDA identified a safety problem. The recall itself does not automatically resolve injury claims or determine compensation. You would still need to demonstrate that you used the drug, that you suffered a qualifying injury, and that the defect caused the harm.
How long do I have to bring a claim in Virginia?
Virginia generally provides two years from the date of injury to file a personal injury lawsuit. In pharmaceutical cases, the clock may start when you discovered, or reasonably should have discovered, the connection between the drug and your injury. Waiting is not advisable. Evidence becomes harder to obtain and legal options narrow as time passes.
Does my case have to go through the same multidistrict litigation as other plaintiffs?
Not necessarily. Some large-scale pharmaceutical cases are coordinated in federal multidistrict litigation, which can affect procedure and timing. Whether to pursue an individual claim, join coordinated litigation, or both depends on the specific drug involved and the facts of your case. An attorney can assess the best path given those circumstances.
What kinds of records do I need to preserve?
Prescription records, pharmacy dispensing records, medical records documenting diagnosis and treatment, and documentation of any communications with your prescriber or the manufacturer are all important. The sooner you gather and preserve these, the better positioned your case will be from the start.
Speak With a Norfolk Pharmaceutical Injury Attorney
A defective drug can alter the course of a person’s health, finances, and daily life in ways that are difficult to fully communicate. The companies that make and distribute these products have legal teams focused on limiting their exposure from the moment a claim surfaces. Montagna Law represents injured people throughout Norfolk, Newport News, Virginia Beach, and the broader Hampton Roads region who have been harmed by dangerous medications. We handle these cases on a contingency fee basis, meaning there are no upfront costs and no attorney fees unless we recover compensation for you. If a pharmaceutical product has caused you or a family member serious harm, contact our firm to discuss your situation with a Norfolk defective drug attorney who will give your case the direct attention it deserves.